The Microsampling Workshop | 28 March 2017 | 8:30-16:50

Hotel Nikko Düsseldorf, Germany


Expand your scientific network in this intimate workshop and receive practical knowledge and personalized suggestions on how to apply blood microsampling in your clinical studies.

The Microsampling Workshop includes case studies from eight industry experts and small-group sessions to address your questions and the latest innovations in:

  • Paediatric studies
  • Theraputic drug monitoring
  • Biomaker analysis
  • Forensic applications
  • Out-patient monitoring 
  • and more


Download the full program for the Düsseldorf event.

 


€50 registration fee, which includes:


 

"The Microsampling Workshop was a productive meeting packed with info, suggestions and ideas. It gave everyone the opportunity to create a network of experts in the field of microsampling and to share knowledge. Hitting the mark by giving the chance to spread innovative results to the public and scientific community, defining potential and benefits as well as limitations, challenges, and recent developments."

Michele Protti, Department of Pharmacy and Biotechnology (FaBiT)

  

 

 

The Microsampling Workshop is presented by Dr. Neil Spooner of Spooner Bioanalytical Solutions Ltd (SBS) and hosted by Neoteryx.  SBS has world class expertise in the development and implementation of technologies and workflows associated with the utilization of microsampling, enabling the delivery of these benefits to users and developers of these technologies. Neoteryx is focused on delivering simple, quantitative, and automatable microsampling solutions for biological sample collection which improve welfare, reduce costs, and enable convenient sample collection anywhere, anytime, by anyone. The Mitra Microsampler class I medical device is for direct specimen collection of blood and other biological fluids. It is not specific to any clinical test, and is not for use in diagnostic procedures. Use of the Mitra Microsampler in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with CLIA requirements. Limit one evaluation device per attendee. Evaluation device subject to availability.